What happens when academia and industry come together to share their passion for innovation and discovery? This synergy was sparked at the MCB Industrial Affiliates Program (IAP) inaugural symposium.
Department News
Below are articles from various sources about members of MCB and their research.
October 10, 2017
October 09, 2017
A group of UC researchers received funding to build the NexGen 7T functional MRI (fMRI) that will "provide the highest resolution images of the brain ever obtained, able to focus on a region the size of a poppy seed."
October 06, 2017
MCB Professor David Bilder contributed this piece to the New York Times, expressing the beauty and importance of basic research -- and how critical it is to continue the government's support of it.
October 05, 2017
Assistant Professor of Genetics, Genomics and Development Hernan Garcia and Assistant Adjunct Professor of Biochemistry, Biophysics and Structural Biology Jacob Corn received New Innovator Awards from the National Institutes of Health (NIH). The award supports highly creative, innovative research that could have implications for human health.
October 04, 2017
A study co-authored by MCB and Chemistry Professor, and HHMI Investigator, Jennifer Doudna details a safer and more effective method of delivering CRISPR-Cas9 gene-editing technology.
October 04, 2017
We have just learned that MCB Emeritus Professor Satyabrata Nandi passed away on July 29th, 2017 in his home in Berkeley at the age of 86. He received his PhD from UC Berkeley in 1957, and ultimately joined us as a faculty member. His career in cancer research and teaching spanned over 40 years and he is still remembered fondly in the department.
September 28, 2017
The lab of MCB Associate Professor Michelle Chang has engineered E. coli to manufacture bioplastics from inorganic fluorides. The product is more durable than non-fluorinated commercial bioplastics, which could make bioplastic production more sustainable.
September 20, 2017
A study co-authored by Associate Professor of MCB and Physics Ahmet Yildiz has revealed a critical region within the Cas9 protein that can be manipulated to improve its target specificity. This has the potential to greatly reduce the risk of inaccurate edits, a key consideration for the future of gene therapy in humans.
September 19, 2017
4D Molecular Therapeutics, co-founded by MCB & BioEngineering Professor David Schaffer has received $3 million in funding from Cystic Fibrosis Foundation Therapeutics Inc.
4D Molecular Therapeutics is a developer and manufacturer of gene therapeutic products. The funding will help them begin clinical trials of a new gene therapy treatment, 4D-710, on cystic fibrosis patients.
September 19, 2017
Congratulations to Florentine Rutaganira (postdoc in Professor Nicole King's Lab), who has been named an HHMI Hanna Gray Fellow. HHMI’s Hanna H. Gray Fellows Program seeks to encourage talented early career scientists who have the potential to become leaders in academic research. Each of the 15 fellows will get up to $1.4M in funding covering Post-doc and assistant professor transitions.